Date de publication: 18 février 2019
Promoteur – Intermédiaire Financier
ALFASIGMA SPALieu
Description
The project will finance Alfasigma's R&D investments to be made in the period 2019-2022. In particular, financing will cover the promoter's research activities (clinical and regulatory development) for the development of innovative drugs in the areas of gastroenterology, vascular medicine and rheumatology.
Objectifs
By co-investing in this project, the EIB contributes to making medical treatments for what the healthcare system considers high priority diseases, whilst also fostering the generation of European scientific knowledge and acumen.
Secteur(s)
- Services - Activités spécialisées, scientifiques et techniques
Montant BEI envisagé (montant approximatif)
EUR 100 million
Coût total (montant approximatif)
EUR 251 million
Aspects environnementaux
The project mainly concerns investments in R&D that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Passation des marchés
Alfasigma is a private company not operating in the utilities sector and not having the status of a contracting authority. Thus, it is not covered by EU Directives on procurement. However, the promoter's procurement procedures are expected to be in line with EIB guidelines for private sector projects. The Bank's services will verify details during the project due diligence.
Statut
Signé - 13/09/2019
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).